Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis

por Ugarte-Berzal, Estefania, Berghmans, Nele, Boon, Lise, Martens, Erik, Vandooren, Jennifer, Cauwe, Bénédicte, Thijs, Greet, Proost, Paul, Van Damme, Jo, Opdenakker, Ghislain
Publicado 2018

Insufficiently Defined Genetic Background Confounds Phenotypes in Transgenic Studies As Exemplified by Malaria Infection in Tlr9 Knockout Mice

por Geurts, Nathalie, Martens, Erik, Verhenne, Sebastien, Lays, Natacha, Thijs, Greet, Magez, Stefan, Cauwe, Bénédicte, Li, Sandra, Heremans, Hubertine, Opdenakker, Ghislain, Van den Steen, Philippe E.
Publicado 2011

Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease

por de Bruyn, Magali, Breynaert, Christine, Arijs, Ingrid, De Hertogh, Gert, Geboes, Karel, Thijs, Greet, Matteoli, Gianluca, Hu, Jialiang, Van Damme, Jo, Arnold, Bernd, Ferrante, Marc, Vermeire, Séverine, Van Assche, Gert, Opdenakker, Ghislain
Publicado 2017